Patrick Frost, PhD

Patrick Frost, PhD

Jan 23, 2016

Group 6 Copy 44
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Conservation Efforts to Protect Endangered Turtles of Sulawesi

Sulawesi, Indonesia, is home to many species found nowhere else on Earth. Although rich in biodiversity, Sulawesi...

Engage Kayamandi Youth in Cape Citizen Science with Vision Afrika

Cape Citizen Science is a project that engages the public in research about plant disease in South Africa. Youth...

Backer Badge Funded